Lisata Therapeutics, Inc.
LSTA
$5.03
-$0.01-0.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -16.70% | -8.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -27.98% | -10.61% | |||
| Operating Income | 30.24% | 9.33% | |||
| Income Before Tax | 30.48% | 8.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 30.48% | 8.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 30.48% | 8.80% | |||
| EBIT | 30.24% | 9.33% | |||
| EBITDA | 29.89% | 9.41% | |||
| EPS Basic | 30.99% | 10.18% | |||
| Normalized Basic EPS | 30.96% | 10.20% | |||
| EPS Diluted | 30.99% | 10.18% | |||
| Normalized Diluted EPS | 30.96% | 10.20% | |||
| Average Basic Shares Outstanding | 0.72% | 1.55% | |||
| Average Diluted Shares Outstanding | 0.72% | 1.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||